Redcare Pharmacy stock trades at EUR 71.63 with EUR 1.4 billion market value
Published on 10/12/2026 at 14:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Redcare Pharmacy stock was at EUR 71.63 at Lang & Schwarz on October 12, 2026, down 0.51 percent versus the Xetra close of EUR 72.00.
- The market capitalization was EUR 1.4 billion and the 52-week range was EUR 30.20 to EUR 89.50.
- The next quarterly statement is scheduled for October 29, 2026.
- DocMorris fell 0.53 percent in Swiss trading, while CVS Health fell 1.86 percent in US trading.
Redcare Pharmacy stock (ISIN NL0012044747) was trading at EUR 71.63 at Lang & Schwarz on October 12, 2026 at 2:33 p.m. CEST, down 0.51 percent versus the Xetra close of EUR 72.00 on October 9, 2026. The market capitalization stood at EUR 1.4 billion on October 12, 2026.
Price remains below yearly high
The current quote sits EUR 17.87 below the 52-week high of EUR 89.50 and 19.97 percent below that level. The 52-week low is EUR 30.20, placing the stock EUR 41.43 above its lower boundary.
Lang & Schwarz showed a bid of EUR 71.45 and an ask of EUR 71.80 at 2:33 p.m. CEST. The spread between the two prices was EUR 0.35, while the quote remained inside the day's wider Xetra-linked trading range of EUR 71.15 to EUR 72.70 reported for the German listing at 12:18 p.m. UTC.
Valuation stays loss-making
Redcare Pharmacy's trailing price-to-earnings ratio was negative 34.26 on October 12, 2026. The negative ratio reflects the company's reported loss position, while the market capitalization gives the valuation figure without assigning a forecast or investment recommendation.
Redcare Pharmacy's investor-relations calendar lists the next quarterly event for October 29, 2026. According to Redcare Pharmacy, the company will publish its third-quarter 2026 interim statement and hold a quarterly conference call on that date.
Comparison with peers
Redcare Pharmacy: minus 0.51 percent, P/E -34.3, market capitalization EUR 1.4 billion
DocMorris (SIX, CHF): minus 0.53 percent, P/E -8.4, market capitalization CHF 647.8 million
CVS Health (NYSE, USD): minus 1.86 percent, P/E 22.8, market capitalization USD 109.9 billion
Trading reference for October 12
At Lang & Schwarz, Redcare Pharmacy was trading at EUR 71.63 on October 12, 2026 at 2:33 p.m. CEST, down 0.51 percent versus the Xetra close of EUR 72.00 on October 9, 2026. The quote remained 19.97 percent below the 52-week high of EUR 89.50. The further course of trading is shown by the continuously updated real-time quote of Redcare Pharmacy stock.
Redcare Pharmacy stock facts
- Company: Redcare Pharmacy N.V.
- ISIN: NL0012044747
- Ticker: RDC
- Primary exchange: Xetra
- Price Lang & Schwarz (as of October 12, 2026, 2:33 p.m. CEST): EUR 71.63
- Change versus Xetra close: minus 0.51 percent
- Xetra close (October 9, 2026): EUR 72.00
- Market capitalization: EUR 1.4 billion (as of October 12, 2026)
- 52-week range: EUR 30.20-EUR 89.50 (as of October 12, 2026)
- Next earnings date: October 29, 2026
Market context: Market report DAX.
